Jasper Therapeutics, Inc. (NASDAQ:JSPRW) Short Interest Update

Jasper Therapeutics, Inc. (NASDAQ:JSPRW) saw a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 20,000 shares, an increase of 13.0% from the October 15th total of 17,700 shares. Based on an average daily volume of 4,700 shares, the short-interest ratio is presently 4.3 days.

Jasper Therapeutics Stock Up 0.4 %

Shares of NASDAQ:JSPRW opened at $0.19 on Monday. Jasper Therapeutics has a 12-month low of $0.04 and a 12-month high of $0.38. The stock’s 50-day moving average price is $0.21 and its 200-day moving average price is $0.21.

About Jasper Therapeutics

Jasper Therapeutics, Inc, a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy.